Skip to content

Evaluation of the Contribution of Low-pressure Intra-abdominal Insufflation for Laparoscopic Colic Resection

Prospective Randomized Evaluation of the Contribution of Low-pressure Intra-abdominal Insufflation for Laparoscopic Colic Resection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04112654
Acronym
LoPreCol
Enrollment
128
Registered
2019-10-02
Start date
2020-06-29
Completion date
2023-10-18
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Disease

Brief summary

The laparoscopic surgery requires gas insufflation in the peritoneal cavity and the operator chooses the intraabdominal insufflation pressure. In general, during a conventional laparoscopy, this pressure is 12 to 15 mmHg. The reduction of the intra-abdominal pressure minimizes the parietal trauma due to the insufflation and could lead to a reduction of the postoperative pains and could allow an earlier recovery. In this study, the investigator propose to evaluate the benefits of a low pressure insufflation (6-8 mmHg) with pressure-controlled insufflator in patients with a mild or malignant colon pathology requiring surgical colic resection. The main objective of the study is to demonstrate that the laparoscopic colic resection at low pressure reduces the theoretical hospital stay of one day compared to the conventional laparoscopy.

Interventions

PROCEDUREConventional pressure laparoscopy

Conventional pressure laparoscopy using conventional insufflator AirSeal®

PROCEDURELow pressure laparoscopy

Low pressure laparoscopy using pressure-controlled insufflator AirSeal®

Sponsors

Institut Paoli-Calmettes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Colic lesion justifying surgical resection by segmental colectomy, * Surgery proposed by laparoscopy, * Body mass index (BMI) ≤30 kg/m2, * Written informed consent signed by the patient, * Patient affiliated to the national French statutory healthcare insurance, system or beneficiary of this regimen.

Exclusion criteria

* Probable realization of a stoma during the procedure, * Robot-assisted approach, * Contraindication to laparoscopic surgery, * Pregnant or likely to be pregnant, * Patient deprived of liberty or placed under the authority of a tutor, * Patient considered geographically socially or psychologically unable to comply with the study procedure and the medical follow-up.

Design outcomes

Primary

MeasureTime frameDescription
The theoretical hospital stayfrom hospitalization day until hospital discharge, assessed up to 15 daysThe theoretical hospital stay in days (calculated from the day of the surgery to the theoretical day of discharge according to predefined exit criteria)

Secondary

MeasureTime frameDescription
Mortality rate20 days post surgeryDead patient listing
GastroIntestinal-Quality-of-Life Index (GIQLI)20 days and 3 months post surgeryGastroIntestinal-Quality-of-Life Index (GIQLI) questionnaire, 36 questions, each containing 4 answers equating to a score ranging from 0 (least desirable answer) to 4 (most desirable answer). Total score range 0-144.
Short Form Health (SF12) score20 days and 3 months post surgeryThis questionnaire is an abbreviated version of the Medical Outcomes Study Short-Form General Health Survey (SF-36) contains only 12 items out of 36 with minimum score 0 (bad quality life) and maximum score at 100 (good quality life).
Pain score using self-report pain assessment tool (EVA)From surgery to hospital discharge assessed up to 15 days, at 20 days and at 3 months post surgeryEVA measures the intensity of pain on a scale of 0 (no pain) to 10 (maximum pain imaginable)
Intestinal transit recovery time frameFrom surgery to transit recovery assessed up to 15 daysPeriod duration from surgery to intestinal gas recovery time (in days)
Morbidity rate20 days post surgeryMorbidity evaluated according Dindo-clavien classification
Analgesic treatment incidenceFrom surgery to 3 months post surgeryNon-morphine and morphine analgesic consumption
Real hospitalization durationFrom hospitalization day until hospital discharge assessed up to 15 daysReal hospitalization duration (actual patient discharge date based on non-medical criteria)
Rehospitalization numberfrom hospital discharge assessed up to 15 days to 3 months post surgeryRehospitalization listing
Differential cost of patient careFrom surgery to hospital discharge assessed up to 15 daysAccording operating room occupation and real hospital stay
Nausea and vomiting incidenceFrom surgery to hospital discharge assessed up to 15 daysNausea and vomiting listing

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026